CliffBio
small molecule

GLYCOPYRROLATE

GLYCOPYRROLATE

Loss of exclusivity—loss of exclusivity
CompanyOMNIVIUM PHARMACEUTICALS LLC

Drug detail

Brand nameGLYCOPYRROLATE
Active ingredientGLYCOPYRROLATE
Strength0.2MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalNovember 2022
Marketing statusRX

More from OMNIVIUM PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

GLYCOPYRROLATE patent cliff — loss of exclusivity — | CliffBio